somatic symptoms disorder with pain predominance. Persistent somatoform pain disorder
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group are treated orally with ketamine dissolved in a glass of fruit juice at a rate of 1 mg/kg twice a week with an interval of 3 days and for 4 w
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Diagnosis of somatic symptom disorder with obvious pain complaint based on DSM-V criteria Informed consent to participate in the study Age group 18-60 years No history of mania/hypomania No presence of symptoms of psychosis in the patient's current or past history No history of drug dependence or abuse in the last 3 months No Pregnancy or lactation No Serious and uncontroled physical patients, including liver, kidney, digestive, respiratory, cardiovascular (such as ischemic heart diseases), endocrine, neurological, increased intraocular pressure or increased cerebrospinal fluid pressure, hematological (on Based on the history of the patient and companions, and if needed, paraclinical examination and consultation) No taking any kind of medicine that is prohibited to use at the same time as ketamine Untreated hypothyroidism or hyperthyroidism. (due to the instability of physical and vital signs)
Exclusion criteria
Exclusion criteria: Emergence of psychosis and psychotic symptoms Patients who became out of reach of the researcher in the follow-up process Annoying and uncontrollable side effects with ketamine use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The intensity of pain measured by visual pain scale tool. Timepoint: Before starting treatment and immediately after treatment and 1 month later. Method of measurement: Visual pain scale tool. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholamreza Kheirabadi
Esfahan University of Medical Sciences
Outcome results
None listed